Swarthmore Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-3,900
Closed -$486K 39
2017
Q1
$486K Sell
3,900
-1,050
-21% -$125K 0.07% 42
2016
Q4
$570K Sell
4,950
-17,775
-78% -$2.05M 0.09% 39
2016
Q3
$2.69M Hold
22,725
0.51% 31
2016
Q2
$2.76M Hold
22,725
0.47% 31
2016
Q1
$2.46M Buy
22,725
+6,100
+37% +$632K 0.38% 34
2015
Q4
$1.71M Sell
16,625
-11,450
-41% -$1.15M 0.18% 35
2015
Q3
$2.62M Buy
+28,075
New +$2.72M 0.28% 31
2015
Q1
Sell
-33,925
Closed -$3.55M 57
2014
Q4
$3.55M Sell
33,925
-7,000
-17% -$738K 0.32% 27
2014
Q3
$4.36M Sell
40,925
-300
-0.7% -$31.1K 0.4% 31
2014
Q2
$4.31M Sell
41,225
-1,800
-4% -$182K 0.45% 31
2014
Q1
$4.23M Sell
43,025
-15,150
-26% -$1.4M 0.5% 26
2013
Q4
$5.33M Sell
58,175
-3,400
-6% -$313K 0.62% 29
2013
Q3
$5.34M Sell
61,575
-7,400
-11% -$664K 0.68% 26
2013
Q2
$5.92M Buy
+68,975
New +$5.85M 0.75% 27

Other funds holding JNJ

Swarthmore Group's JNJ Position: Q2 2017 in Review

Swarthmore Group sold out of Johnson & Johnson (JNJ) in Q2 2017, closing a stake of 3,900 shares — an estimated $486K sold.

Swarthmore Group first reported a position in JNJ in Q2 2013 and held it in 14 quarters. The position peaked at $5.92M in Q2 2013. 2,349 funds tracked by Wall St. Rank hold JNJ as of Q2 2017.

  • Swarthmore Group reported no remaining Johnson & Johnson position as of Q2 2017 after selling out during the quarter.
  • Swarthmore Group sold 3,900 Johnson & Johnson shares in Q2 2017, an estimated $486K.
  • Swarthmore Group first reported a position in Johnson & Johnson in Q2 2013 and held it in 14 quarters.
  • Swarthmore Group's Johnson & Johnson position peaked at $5.92M in Q2 2013.
  • 2,349 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2017.

Based on Swarthmore Group's 13F filing for Q2 2017, filed 5 Jul 2017.